Public Inspection: CMS: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

Federal Register

Nov 6, 2026

Pre-publication notice of a final rule from the Centers for Medicare & Medicaid Services (CMS) that codifies the Medicare Drug Price Negotiation Program, establishes certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and finalizes a proposed modification to the fixed combination drug policy. These regulations are effective December 5, 2026, and are applicable to the Negotiation Program with respect to initial price applicability year 2029 and to Part D Program coverage beginning January 1, 2029.

Healthcare business and finance · Legislation and regulations · Medicare · Pharmacy and prescription drugs